Full text
PDF![1105](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/755f/488329/f196bba7bb7d/jnnpsyc00522-0087.png)
![1106](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/755f/488329/b675311650b8/jnnpsyc00522-0088.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beal M. F., Growdon J. H., Mazurek M. F., Martin J. B. CSF somatostatin-like immunoreactivity in dementia. Neurology. 1986 Feb;36(2):294–297. doi: 10.1212/wnl.36.2.294. [DOI] [PubMed] [Google Scholar]
- Davies P., Katzman R., Terry R. D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature. 1980 Nov 20;288(5788):279–280. doi: 10.1038/288279a0. [DOI] [PubMed] [Google Scholar]
- Dupont E., Christensen S. E., Hansen A. P., de Fine Olivarius B., Orskov H. Low cerebrospinal fluid somatostatin in Parkinson disease: an irreversible abnormality. Neurology. 1982 Mar;32(3):312–314. doi: 10.1212/wnl.32.3.312. [DOI] [PubMed] [Google Scholar]
- Epelbaum J., Ruberg M., Moyse E., Javoy-Agid F., Dubois B., Agid Y. Somatostatin and dementia in Parkinson's disease. Brain Res. 1983 Nov 14;278(1-2):376–379. doi: 10.1016/0006-8993(83)90277-9. [DOI] [PubMed] [Google Scholar]
- Sperk G., Widmann R. Somatostatin precursor in the rat striatum: changes after local injection of kainic acid. J Neurochem. 1985 Nov;45(5):1441–1447. doi: 10.1111/j.1471-4159.1985.tb07211.x. [DOI] [PubMed] [Google Scholar]